FAM
Formidable Asset Management’s Royalty Pharma RPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.23M | Sell |
35,425
-1,450
| -4% | -$50.2K | 0.21% | 92 |
|
|
2025
Q1 | $1.15M | Sell |
36,875
-36
| -0.1% | -$1.12K | 0.19% | 99 |
|
|
2024
Q4 | $942K | Buy |
36,911
+4,226
| +13% | +$108K | 0.15% | 126 |
|
|
2024
Q3 | $925K | Sell |
32,685
-898
| -3% | -$25.4K | 0.15% | 134 |
|
|
2024
Q2 | $886K | Sell |
33,583
-3,844
| -10% | -$101K | 0.14% | 137 |
|
|
2024
Q1 | $1.14M | Sell |
37,427
-3,183
| -8% | -$96.7K | 0.19% | 112 |
|
|
2023
Q4 | $1.14M | Sell |
40,610
-936
| -2% | -$26.3K | 0.24% | 80 |
|
|
2023
Q3 | $1.12M | Buy |
41,546
+5,022
| +14% | +$135K | 0.25% | 79 |
|
|
2023
Q2 | $1.12M | Buy |
36,524
+3,666
| +11% | +$113K | 0.25% | 76 |
|
|
2023
Q1 | $1.18M | Buy |
32,858
+8,137
| +33% | +$293K | 0.25% | 76 |
|
|
2022
Q4 | $977K | Buy |
24,721
+3,431
| +16% | +$136K | 0.22% | 89 |
|
|
2022
Q3 | $856K | Buy |
21,290
+567
| +3% | +$22.8K | 0.2% | 96 |
|
|
2022
Q2 | $872K | Buy |
20,723
+2,131
| +11% | +$89.7K | 0.2% | 100 |
|
|
2022
Q1 | $724K | Buy |
18,592
+8,350
| +82% | +$325K | 0.14% | 132 |
|
|
2021
Q4 | $408K | Sell |
10,242
-7,238
| -41% | -$288K | 0.08% | 211 |
|
|
2021
Q3 | $632K | Buy |
17,480
+920
| +6% | +$33.3K | 0.12% | 167 |
|
|
2021
Q2 | $660K | Buy |
+16,560
| New | +$660K | 0.14% | 152 |
|